Mylan Green/Dirty Deed And Now Imprimisis to release dramatically lower cost option

So Mylan pulled a Turing Pharmaceuticals, jacking up the price of its EpiPen. Then, when they were busted, "Ooops, sorry, we are now offering some discounts." Now Imprimis Pharamaceuticals will be introducing an option by year end - at likely less than a third of the newly reduced Mylan price. When will those with profit myopia realize the world is watching - and there is price to pay for greed.

How EpiPen came to symbolize corporate greed

EpiPen main ingredient costs 'less than a Big Mac'